Islamabad: The federal authorities allowed pharma corporations to extend the costs of medicines by 7 to 10%.
According to Express News, the federal authorities allowed pharmaceutical corporations to extend the costs of medicines below the Consumer Price Index (CCI). According to the DRAP notification, pharmaceutical corporations and importers are allowed to extend the costs of fundamental medicines by 7% and different medicines by 10%.
According to the notification, DRAP has amended the Drug Pricing Policy 2018 with the approval and suggestion of the Federal Government and the DRAP Policy Board. The Ministry of National Health will improve the costs of medicines yearly in keeping with the Consumer Price Index (CPI).
On the opposite hand, the residents have termed the rise within the costs of medicines as an injustice to the folks and demanded from the federal government that the costs of medicines are already very excessive and no additional improve must be made.
Last 12 months, in keeping with the Consumer Price Index (CPI), costs of fundamental medicines had been allowed to extend by 5.14% whereas costs of all different medicines had been allowed to extend by 7.34%.